Massar Omar

1.4k total citations
34 papers, 798 citations indexed

About

Massar Omar is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Massar Omar has authored 34 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 14 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Surgery. Recurrent topics in Massar Omar's work include Cardiovascular Function and Risk Factors (19 papers), Diabetes Treatment and Management (14 papers) and Pancreatic function and diabetes (11 papers). Massar Omar is often cited by papers focused on Cardiovascular Function and Risk Factors (19 papers), Diabetes Treatment and Management (14 papers) and Pancreatic function and diabetes (11 papers). Massar Omar collaborates with scholars based in Denmark, United States and Germany. Massar Omar's co-authors include Barry A. Borlaug, Finn Gustafsson, Jacob Eifer Møller, Morten Schou, J. Steen Jensen, Caroline Kistorp, Lars Køber, Hidemi Sorimachi, Yogesh N.V. Reddy and Christian Tuxen and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Massar Omar

27 papers receiving 784 citations

Peers

Massar Omar
Matteo Serenelli Italy
Eva M. Boorsma Netherlands
Rodolfo San Antonio Spain
Licette C.Y. Liu Netherlands
Ayako Nagumo Japan
Akimichi Iwamoto Japan
Yoshiaki Kubota Japan
Davide Giorgi Italy
Caterina Colantonio Austria
Ingrid Hriljac United States
Matteo Serenelli Italy
Massar Omar
Citations per year, relative to Massar Omar Massar Omar (= 1×) peers Matteo Serenelli

Countries citing papers authored by Massar Omar

Since Specialization
Citations

This map shows the geographic impact of Massar Omar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massar Omar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massar Omar more than expected).

Fields of papers citing papers by Massar Omar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massar Omar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massar Omar. The network helps show where Massar Omar may publish in the future.

Co-authorship network of co-authors of Massar Omar

This figure shows the co-authorship network connecting the top 25 collaborators of Massar Omar. A scholar is included among the top collaborators of Massar Omar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massar Omar. Massar Omar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Omar, Massar, et al.. (2025). Suspected liraglutide (glucagon-like peptide-1 receptor agonist)-induced hyperthyroidism: A case report. Malaysian Family Physician. 20. 58–58.
2.
3.
Emanuelsson, Frida, J. Steen Jensen, Massar Omar, et al.. (2024). Effect of empagliflozin on plasma lipids and lipoproteins in type 2 diabetes and heart failure – Empire HF and SIMPLE. Journal of clinical lipidology. 19(2). 276–285. 1 indexed citations
4.
Jensen, J. Steen, Massar Omar, Caroline Kistorp, et al.. (2024). Empagliflozin to elderly and obese patients with increased risk of developing heart failure: Study protocol for the Empire Prevent trial program. American Heart Journal. 271. 84–96. 1 indexed citations
5.
6.
7.
Omote, Kazunori, Hidemi Sorimachi, Masaru Obokata, et al.. (2023). Biatrial Myopathy in Heart Failure with Preserved Ejection Fraction. European Journal of Heart Failure. 26(2). 288–298. 13 indexed citations
8.
Larson, Kathryn F., Massar Omar, Hidemi Sorimachi, et al.. (2023). Clinical Phenogroup Diversity and Multiplicity: Impact on Mechanisms of Exercise Intolerance in Heart Failure with Preserved Ejection Fraction. European Journal of Heart Failure. 26(3). 564–577. 6 indexed citations
9.
Borlaug, Barry A., Yogesh N.V. Reddy, A Braun, et al.. (2023). Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial. Circulation. 148(10). 834–844. 62 indexed citations
10.
Omar, Massar, Kazunori Omote, Hidemi Sorimachi, et al.. (2023). Hypoxaemia in Patients with Heart Failure and Preserved Ejection Fraction. European Journal of Heart Failure. 25(9). 1593–1603. 9 indexed citations
11.
Alogna, Alessio, Massar Omar, Dejana Popović, et al.. (2023). Biventricular Cardiac Power Reserve in Heart Failure with Preserved Ejection Fraction. European Journal of Heart Failure. 25(7). 956–966. 5 indexed citations
12.
Popović, Dejana, Alessio Alogna, Massar Omar, et al.. (2023). Ventricular Stiffening and Chamber Contracture in Heart Failure with Higher Ejection Fraction. European Journal of Heart Failure. 25(5). 657–668. 39 indexed citations
13.
Borlaug, Barry A., Katlyn E. Koepp, Yogesh N.V. Reddy, et al.. (2023). Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in Heart Failure With Preserved Ejection Fraction: The INABLE-Training Trial. Mayo Clinic Proceedings. 99(2). 206–217. 11 indexed citations
14.
Omar, Massar, J. Steen Jensen, Caroline Kistorp, et al.. (2022). The effect of empagliflozin on growth differentiation factor 15 in patients with heart failure: a randomized controlled trial (Empire HF Biomarker). Cardiovascular Diabetology. 21(1). 34–34. 21 indexed citations
15.
Jensen, J. Steen, Massar Omar, Peter Frederiksen, et al.. (2022). The effect of empagliflozin on contractile reserve in heart failure: Prespecified sub-study of a randomized, double-blind, and placebo-controlled trial. American Heart Journal. 250. 57–65. 1 indexed citations
16.
Sorimachi, Hidemi, Kazunori Omote, Massar Omar, et al.. (2022). Sex and central obesity in heart failure with preserved ejection fraction. European Journal of Heart Failure. 24(8). 1359–1370. 49 indexed citations
17.
Omar, Massar, Christoffer Polcwiartek, Jesper Fleischer, et al.. (2021). Cardiovascular autonomic neuropathy in patients with schizophrenia. Nordic Journal of Psychiatry. 75(7). 547–552. 5 indexed citations
18.
19.
Jensen, J. Steen, Massar Omar, Caroline Kistorp, et al.. (2019). Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF). Trials. 20(1). 374–374. 40 indexed citations
20.
Longenecker, J. Craig, et al.. (2009). Association of Low Heart Rate Variability with Atherosclerotic Cardiovascular Disease in Hemodialysis Patients. Medical Principles and Practice. 18(2). 85–92. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matteo Serenelli Breakdown of academic impact, for papers by Eva M. Boorsma Breakdown of academic impact, for papers by Rodolfo San Antonio Breakdown of academic impact, for papers by Licette C.Y. Liu Breakdown of academic impact, for papers by Ayako Nagumo Breakdown of academic impact, for papers by Akimichi Iwamoto Breakdown of academic impact, for papers by Yoshiaki Kubota Breakdown of academic impact, for papers by Davide Giorgi Breakdown of academic impact, for papers by Caterina Colantonio Breakdown of academic impact, for papers by Ingrid Hriljac
Rankless by CCL
2026